XML 20 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated OCI
Accumulated Deficit
Total
Balance (in shares) at Dec. 31, 2018 8,411,245        
Balance at Dec. 31, 2018 $ 84,113 $ 94,926,560 $ (186,485) $ (70,407,218) $ 24,416,970
Common stock repurchased, shares (86,373)        
Common stock repurchased, amount $ (865) (364,820)     (365,685)
Issuance of common stock restricted (in shares) 66,274        
Issuance of common stock restricted $ 663 (663)     0
Issuance of common stock through at-the-market offering program, net of issuance costs of $333,305 amount         0
Cancellation of common stock, shares (5,000)        
Cancellation of common stock, amount $ (50) 50     0
Stock compensation expense restricted   381,251     381,251
Stock compensation expense non-qualified stock options   336,736     336,736
Foreign currency translation gain     (56,109)   (56,109)
Net loss       226,255 226,255
Balance (in shares) at Dec. 31, 2019 8,386,146        
Balance at Dec. 31, 2019 $ 83,861 95,279,114 (242,594) (70,180,963) 24,939,418
Reverse split adjustment   (75,475) 75,475   0
Issuance of shares for rounding on the reverse split, shares 2,546        
Issuance of shares for rounding on the reverse split, amount $ 2 (2)     0
Common stock repurchased, shares (2,416)        
Common stock repurchased, amount $ (2) (10,111)     (10,113)
Issuance of common stock options exercises (in shares) 32,803        
Issuance of common stock options exercises $ 33 4,966     4,999
Issuance of common stock restricted (in shares) 58,123        
Issuance of common stock restricted $ 58 (58)     0
Issuance of common stock through at-the-market offering program, net of issuance costs of $333,305, shares 399,313        
Issuance of common stock through at-the-market offering program, net of issuance costs of $333,305 amount $ (399) (4,345,076)     4,345,475
Stock compensation expense restricted   704,973     704,973
Stock compensation expense non-qualified stock options   105,308     105,308
Foreign currency translation gain     137,979   137,979
Net loss       10,323,684 10,323,684
Balance (in shares) at Dec. 31, 2020 8,876,515        
Balance at Dec. 31, 2020 $ 8,876 $ 100,504,741 $ (104,615) $ (59,857,279) $ 40,551,723